BEIJING – Five years after the COVID-19 pandemic began, China is now facing another outbreak, this time of the human metapneumovirus (HMPV), along with a rise in various respiratory pathogens, including Influenza A, Mycoplasma pneumoniae, and COVID-19. Reports and viral posts on social media depict a troubling scene of overcrowded hospitals and crematoriums, with healthcare facilities struggling to cope with the increasing number of cases. Videos shared online show packed medical centers, especially children's hospitals, overwhelmed by pneumonia cases and the so-called “white lung” condition, raising further alarm.
Claims of a State of Emergency
Unverified reports indicate that China may have declared a state of emergency as the epidemic spreads. A widely circulated post from the X account “SARS-CoV-2 (Covid-19)” claimed: “China is experiencing a surge in multiple viruses, including Influenza A, HMPV, Mycoplasma pneumoniae, and Covid-19, overwhelming hospitals and crematoriums. Children's hospitals are particularly burdened by rising cases of pneumonia and 'white lung' conditions.”
Rising Cases and Health Authorities' Response
From December 16 to 22, there was an increase in acute respiratory disease cases, with experts forecasting further rises in respiratory infections during the winter and spring. However, officials mentioned that the total number of cases this year is anticipated to be lower than last year's figures. To address the situation, China’s disease control authority has initiated a pilot monitoring system for pneumonia of unknown origin, aiming to fill gaps identified during the early stages of the COVID-19 pandemic. New measures include improved laboratory reporting procedures and case verification protocols to enhance tracking and management of emerging pathogens.
Pathogens on the Rise
Respiratory infections caused by rhinovirus and HMPV are becoming more common, especially among those under 14 in northern provinces. HMPV usually leads to symptoms similar to a cold, including fever, cough, and breathing difficulties. However, experts caution that in severe cases, particularly for children and older adults, the virus can result in bronchitis or pneumonia. A respiratory expert from Shanghai warned against the excessive use of antiviral medications, highlighting that there is currently no vaccine for HMPV. “The virus should be treated like other respiratory illnesses, and unnecessary drug use could make things worse,” the expert stated to the state-run National Business Daily.
Public Concern and Lunar New Year Travel
Public anxiety is rising as the outbreak coincides with the approach of the Lunar New Year, a time known for high levels of domestic and international travel. Critics are concerned that increased movement during the holiday could worsen the spread of HMPV and other viruses. A viral tweet raised alarms about potential cross-border transmission:
“With respiratory infections like HMPV rising in China, how will authorities manage the risk of spread as Chinese tourists travel to Japan and other countries during the Lunar New Year?”
Lessons from the Past
Drawing on lessons from the COVID-19 pandemic, health authorities in China are working to improve their preparedness. However, the swift spread of HMPV and other respiratory viruses highlights the difficulties of managing multiple outbreaks at once. As the situation develops, the global health community is keeping a close eye on events in China, with worries that the outbreak could have broader implications beyond the country's borders.